GlassScriptPhysician profile
Sergey Kravchick
NPI 1548789662
$1,150.87
in general payments reported to CMS, 2019-2025
17 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $37.25 · 2021: $396 · 2023: $57.74 · 2024: $157 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.23 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $421.66 | 2021-2023 | Urolift |
| Coloplast Corp | $129.41 | 2019 | |
| Sumitomo Pharma America, INC. | $77.49 | 2024-2025 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $59.60 | 2024-2025 | Prolaris, Myrisk |
| Tolmar Pharmaceuticals, INC. | $54.22 | 2019 | |
| Cardinal Health 414 LLC | $50.67 | 2024 | |
| Boston Scientific Corporation | $50.53 | 2019-2024 | Lithovue |
| Neotract INC. | $40.01 | 2019 | |
| Laborie Medical Technologies Corp. | $37.41 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $37.25 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Karl Storz Endoscopy-America | $33.21 | 2019 | |
| Axonics, INC. | $32.19 | 2023 | Axonics |
| Abbvie INC. | $25.84 | 2025 | |
| Ferring Pharmaceuticals INC. | $25.83 | 2025 | Adstiladrin |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $22.77 | 2024 | |
| Endo Pharmaceuticals INC. | $17.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Kravchick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.